Semaglutide reduces urine albumin-to-creatinine ratio in overweight chronic kidney disease patients

Researchers investigate the clinical efficacy of semaglutide in controlling urine albumin-to-creatinine ratio in overweight patients with chronic kidney disease.

Video of Stem Cell Injection Alarms Doctors

Doctors have been raising questions about a video on social media of a physician allegedly injecting stem cells into the carotid artery of a fully

June 9, 2023

Samsung Bio and Baxter dial up manufacturing deal to $223M

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 20, 2024

Innovent’s Dupert secures approval in China for lung cancer treatment

The approval of Dupert is grounded in the outcomes of a Phase II clinical study. Credit: mi_viri/Shutterstock. China’s National Medical Products Administration (NMPA) has granted

August 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.